| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 180 | $0.35 | $62.18 (0%) | 🛒 Add to cart |
| 360 | $0.31
Best per cap | $124.37 $111.33 (10%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.67 | $40.12 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $60.18 $54.16 (10%) | 🛒 Add to cart |
| 120 | $0.56 | $80.24 $67.20 (16%) | 🛒 Add to cart |
| 180 | $0.53 | $120.35 $95.28 (21%) | 🛒 Add to cart |
| 270 | $0.51 | $180.53 $137.40 (24%) | 🛒 Add to cart |
| 360 | $0.50
Best per cap | $240.71 $179.53 (25%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
Fluoxetine: Evidence-Based Treatment for Depression and Related Conditions - Comprehensive Review
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), represents one of the most extensively studied and widely prescribed antidepressants in modern psychopharmacology. Initially approved by the FDA in 1987, this molecule fundamentally changed depression treatment paradigms and expanded into numerous psychiatric and even some off-label uses. What’s fascinating isn’t just its mechanism—which we’ll explore in depth—but how its clinical application has evolved through decades of real-world experience across millions of patients worldwide.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily block dopamine D2 receptors, aripiprazole functions as a partial dopamine agonist - a mechanism that both stimulates and blocks dopamine receptors depending on the brain’s dopamine levels. This unique pharmacological profile has positioned it as a versatile treatment option across multiple psychiatric conditions, from schizophrenia and bipolar disorder to adjunctive treatment for major depressive disorder.
Anafranil: Potent OCD Symptom Control Through Serotonin Modulation - Evidence-Based Review
Anafranil, known generically as clomipramine hydrochloride, is a tricyclic antidepressant (TCA) belonging to the dibenzazepine class. It’s primarily indicated for the treatment of obsessive-compulsive disorder (OCD), acting as a potent serotonin reuptake inhibitor. Its significance in modern psychopharmacology stems from its robust efficacy in treatment-resistant OCD cases, often where SSRIs have failed. The drug’s multifaceted mechanism also lends itself to off-label uses in depression, panic disorder, and certain chronic pain conditions, making it a versatile tool in clinical psychiatry.
Antivert: Effective Vertigo and Motion Sickness Relief - Evidence-Based Review
Product Description: Antivert represents one of the most established pharmacological interventions for vestibular disorders, specifically formulated as meclizine hydrochloride. This antihistamine and antiemetic agent has been a cornerstone in managing vertigo and motion sickness for decades, offering predictable symptom relief through central nervous system modulation. Unlike newer supplements with limited regulatory oversight, Antivert maintains FDA approval status with extensive clinical documentation supporting its efficacy profile across multiple patient populations. The standard 12.
Bystolic: Advanced Beta-Blocker Therapy for Hypertension and Cardiovascular Protection - Evidence-Based Review
Bystolic represents one of those interesting cases in cardiovascular pharmacology where we got more than we initially bargained for. When I first started prescribing nebivolol back in 2008, most of us saw it as just another beta-blocker - maybe a bit more cardioselective than metoprolol, but essentially the same mechanism. What we discovered over the subsequent decade fundamentally changed how I approach hypertension management, particularly in complex patients with multiple comorbidities.
Coreg: Improved Survival in Heart Failure - Evidence-Based Review
Coreg, known generically as carvedilol, is a non-selective beta-blocker with additional alpha-1 blocking activity, primarily used in the management of cardiovascular conditions like heart failure, hypertension, and post-myocardial infarction. It’s not a dietary supplement but a prescription medication that works by blocking certain receptors in the heart and blood vessels, leading to reduced heart rate, blood pressure, and cardiac workload. This makes it a cornerstone in treating chronic heart failure, especially with reduced ejection fraction, where it has been shown to improve survival and reduce hospitalizations.
Dapoxetine: Rapid-Onset Treatment for Premature Ejaculation - Evidence-Based Review
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed for the on-demand treatment of premature ejaculation (PE) in men aged 18-64 years. Unlike conventional SSRIs used for depression that require weeks of daily dosing to exert effects, dapoxetine’s unique pharmacokinetic profile allows for rapid absorption and elimination, making it suitable for use approximately 1-3 hours before anticipated sexual activity. Approved in several countries but not by the US FDA, it represents the first oral medication specifically indicated for this prevalent sexual health condition, addressing a significant unmet need in sexual medicine.
dramamine
Dimenhydrinate, marketed under the brand name Dramamine, represents one of the most established over-the-counter solutions for motion sickness and vertigo. This antihistamine medication has been a staple in travel kits and emergency departments for decades, offering reliable symptomatic relief through its well-characterized anticholinergic and H1-receptor blocking properties. What makes Dramamine particularly interesting isn’t just its efficacy—which we’ll explore in depth—but its fascinating dual mechanism that addresses both the neurological and gastrointestinal components of motion-related discomfort.
effexor xr
Effexor XR, known generically as venlafaxine hydrochloride, is an extended-release antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. It’s primarily prescribed for major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder. The “XR” formulation allows for once-daily dosing, improving adherence and maintaining stable plasma levels, which is crucial for managing these chronic conditions. Its dual mechanism targeting both serotonin and norepinephrine sets it apart from selective serotonin reuptake inhibitors (SSRIs), offering an alternative for patients with inadequate response to first-line treatments.